Patents by Inventor Christopher Larson

Christopher Larson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7897599
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: March 1, 2011
    Assignee: iTherX Pharmaceuticals Inc.
    Inventors: Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy G. J. Delaet, Justin Ernst, Antonio Garrido Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhinjun Wang
  • Patent number: 7863012
    Abstract: The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells has shown to be important. However, there are two sources of damage: in vivo and in vitro. Damage in vivo occurs by apoptosis, necrosis, or immune response. Damage in vitro occurs during sample acquisition, handling, transport, processing, or analysis. It is therefore desirable to confine, reduce, eliminate, or at least qualify in vitro damage to prevent it from interfering in analysis. Described herein are methods to diagnose, monitor, and screen disease based on circulating rare cells, including malignancy as determined by CTC, clusters, fragments, and debris. Also provided are kits for assaying biological specimens using these methods.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: January 4, 2011
    Assignee: Veridex, LLC
    Inventors: Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W. M. M. Terstappen, Shawn Mark O'Hara, Steven Gross
  • Publication number: 20100273797
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions medicated by cytokines such as arthritis.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 28, 2010
    Inventors: Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy G. J. Delaet, Justin Ernst, Antonio Garrido Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhijun Wang
  • Patent number: 7749999
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: July 6, 2010
    Assignee: Itherx Pharmaceuticals, Inc.
    Inventors: Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy G. J. Delaet, Justin Ernst, Antonio Garrido Montalban, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhinjun Wang, Jeffrey Kahl, Christopher Larson
  • Publication number: 20100093735
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Application
    Filed: December 14, 2009
    Publication date: April 15, 2010
    Applicants: iTherx Pharmaceuticals, Inc.
    Inventors: Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy G.J. Delaet, Justin Ernst, Antonio Garrido Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhinjun Wang
  • Publication number: 20100093734
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Application
    Filed: December 14, 2009
    Publication date: April 15, 2010
    Applicants: iTherx Pharmaceuticals, Inc.
    Inventors: Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy G.J. Delaet, Justin Ernst, Antonio Garrido Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhijun Wang
  • Patent number: 7590572
    Abstract: A system and method for facilitating a transition from being a dependent of a parent tax filer to being a newly independent tax filer may include determining if a prior-year dependent will be responsible for filing his or her own tax return. The system and method may include obtaining permission from the parent tax filer to offer an evaluation of a tax program to the newly independent tax filer. If permission is granted, information relevant to the newly independent tax filer may be extracted from the parent tax filer's tax information. An invitation to evaluate the tax program may be sent to the newly independent tax filer on behalf of the parent tax filer. If the invitation is accepted, the extracted information may be used to seed a current tax return for the newly independent tax filer. If not, the extracted information may be deleted.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: September 15, 2009
    Assignee: Intuit Inc.
    Inventor: Christopher A. Larson
  • Publication number: 20080147494
    Abstract: A system and method for facilitating a transition from being a dependent of a parent tax filer to being a newly independent tax filer may include determining if a prior-year dependent will be responsible for filing his or her own tax return. The system and method may include obtaining permission from the parent tax filer to offer an evaluation of a tax program to the newly independent tax filer. If permission is granted, information relevant to the newly independent tax filer may be extracted from the parent tax filer's tax information. An invitation to evaluate the tax program may be sent to the newly independent tax filer on behalf of the parent tax filer. If the invitation is accepted, the extracted information may be used to seed a current tax return for the newly independent tax filer. If not, the extracted information may be deleted.
    Type: Application
    Filed: December 14, 2006
    Publication date: June 19, 2008
    Inventor: Christopher A. Larson
  • Publication number: 20070212700
    Abstract: Methods of using biological sequence data. Evolved biological sequences may be used to identify the defining biological characteristics of the sequences—the three-dimensional structure and biochemical function. Some of the present methods extract such information, use such information to predict functional mechanism, and/or use such information in the design of artificial biological sequences. Other methods are included, as are related computer readable media and computer systems.
    Type: Application
    Filed: September 7, 2006
    Publication date: September 13, 2007
    Inventors: Rama Ranganathan, William Russ, Christopher Larson, Rohit Sharma
  • Publication number: 20070005009
    Abstract: A tubular transition member having an annular wall with at least one cut extending through the annular wall is disclosed for controlling a transition in stiffness of a catheter from a stiffer more pushable proximal section to a more flexible and trackable distal section and increasing kink resistance. The transition member may extend across the junction formed between the stiffer proximal section and the more flexible distal section. The transition member may be used in conjunction with any type of catheter including single-operator-exchange type catheters, over-the wire type catheters, and/or fixed-wire type catheters.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 4, 2007
    Inventors: Christopher Larson, Angela Volk
  • Patent number: 7153561
    Abstract: In a substrate having a graphic and a method for applying the graphic thereto, a non-phosphorescent material is applied to the substrate to define a non-phosphorescent region of the graphic and a phosphorescent material is applied to the substrate to define a phosphorescent region of the graphic. At least a portion of the non-phosphorescent region and at least a portion of the phosphorescent region are in overlapping relationship with each other so as to define an overlapping region of the graphic. When the overlapping region is exposed to light sufficient to cause phosphorescence of the phosphorescent region the at least a portion of the phosphorescent region phosphoresces to render the overlapping region visible in the absence of light. In another embodiment, the graphic has a non-photoluminescent region in overlapping relationship with a photoluminescent region.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: December 26, 2006
    Assignee: Kimberly-Clark Wordwide, Inc.
    Inventors: Todd Christopher Larson, Mark M. Mleziva, Michael Donald Sperl, Paula Mary Sosalla
  • Publication number: 20060176967
    Abstract: Time correlation of signal to distortion characteristics is achieved by acquiring time domain data for a frequency band representing a communication signal, the communication signal having multiple channels. The time domain data is simultaneously converted to frequency and demodulation domain data in sequential time blocks. The frequency and demodulation domain data are processed to obtain respectively frequency and demodulation domain measurements. The resulting measurements are displayed simultaneously as a function of time for all the time blocks and/or for a selected one of the time blocks. An ACLRogram display provides a display having a time axis and a frequency axis in the form of bars spanning the frequency band for each time block with each bar being divided into frequency sub-bands representing a main channel and adjacent side channels, the shading of each segment of the bar representing a measurement value for that segment.
    Type: Application
    Filed: February 7, 2005
    Publication date: August 10, 2006
    Inventors: Steven Stanton, John Turpin, Christopher Larson
  • Publication number: 20060134162
    Abstract: A drug delivery device for placement in the eye includes a drug core comprising a pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes a layer of material permeable to passage of the active agent. This invention provides improved methods that do not require the use of adhesives to form the drug delivery device.
    Type: Application
    Filed: December 16, 2004
    Publication date: June 22, 2006
    Inventor: Christopher Larson
  • Patent number: 6949089
    Abstract: A method of concurrently providing a series of types of pant-like garments and corresponding information to consumers. The series includes two or more pant-like garments, each of the garments corresponding to a stage of toilet training. Each of the garments in the series may differ from one another in terms of absorbent capacity, size, and/or features. The information provided to the consumer helps the consumer discern which garment from the series is most appropriate for a child in a specific stage of the toilet training process.
    Type: Grant
    Filed: December 11, 2002
    Date of Patent: September 27, 2005
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Christopher Peter Olson, Shirlee Ann Weber, Mark Michael Mleziva, Sherry Ann Van Dyke, Angela Rae Eder, Todd Christopher Larson, Cynthia Louise Wyngaard
  • Publication number: 20050201586
    Abstract: An electro-acoustic transducer for driving a large surface is used to convert electrical signals into sound. The transducer has a housing with a cast aluminum bottom and a molded plastic top. The top and bottom are fastened together by screws with a gasket in between the contacting surfaces to form a housing for a high power electromagnetic voice coil driver mechanism. The top has an opening to allow the voice coil to be centered in its gap by a centering gauge during assembly of the driver. A cap closes the opening once the voice coil is fixed in place in the housing. The op is hexagonal and flat with circular rings in the top surface to allow the top to flex in a controlled manner while supporting the bottom which remains stationary.
    Type: Application
    Filed: March 10, 2004
    Publication date: September 15, 2005
    Inventors: Dean Rivera, Christopher Larson
  • Publication number: 20050181463
    Abstract: The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells has shown to be important. However, there are two sources of damage: in vivo and in vitro. Damage in vivo occurs by apoptosis, necrosis, or immune response. Damage in vitro occurs during sample acquisition, handling, transport, processing, or analysis. It is therefore desirable to confine, reduce, eliminate, or at least qualify in vitro damage to prevent it from interfering in analysis. Described herein are methods to diagnose, monitor, and screen disease based on circulating rare cells, including malignancy as determined by CTC, clusters, fragments, and debris. Also provided are kits for assaying biological specimens using these methods.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 18, 2005
    Inventors: Galla Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon Terstappen, Shawn O'Hara, Steven Gross
  • Patent number: 6902796
    Abstract: A simplified elastic laminate is made from nonwovens and is especially suitable for side panels of training pant garments or the like. A plurality of thermoplastic adhesive elastomeric fibers are located between first and second facing webs. The fibers have an elastic core and adhesive surfaces. The facing webs, with the elastomeric fibers between them, are calendered together thus adhering the facing webs together via contact adhesion with the elastomeric fibers.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: June 7, 2005
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Charles Morell, James Russell Fitts, Jr., Bryan D. Haynes, Leslie D. Dobbins, Donald V. Willitts, Stephen Michael Campbell, Howard Martin Welch, Todd Christopher Larson, Mark Michael Mleziva, Adrian Roy Eggen
  • Publication number: 20050107399
    Abstract: The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.
    Type: Application
    Filed: September 10, 2004
    Publication date: May 19, 2005
    Inventors: Erik Boman, Susana Ceide, Russell Dahl, Nancy Delaet, Justin Ernst, Antonio Montalban, Jeffrey Kahl, Christopher Larson, Stephen Miller, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Robert Sullivan, Zhijun Wang
  • Publication number: 20030135186
    Abstract: A method of concurrently providing a series of types of pant-like garments and corresponding information to consumers. The series includes two or more pant-like garments, each of the garments corresponding to a stage of toilet training. Each of the garments in the series may differ from one another in terms of absorbent capacity, size, and/or features. The information provided to the consumer helps the consumer discern which garment from the series is most appropriate for a child in a specific stage of the toilet training process.
    Type: Application
    Filed: December 11, 2002
    Publication date: July 17, 2003
    Inventors: Christopher Peter Olson, Shirlee Ann Weber, Mark Michael Mleziva, Sherry Ann Van Dyke, Angela Rae Eder, Todd Christopher Larson, Cynthia Louise Wyngaard
  • Publication number: 20030124331
    Abstract: A simplified elastic laminate is made from nonwovens and is especially suitable for side panels of training pant garments or the like. A plurality of thermoplastic adhesive elastomeric fibers are located between first and second facing webs. The fibers have an elastic core and adhesive surfaces. The facing webs, with the elastomeric fibers between them, are calendered together thus adhering the facing webs together via contact adhesion with the elastomeric fibers.
    Type: Application
    Filed: December 28, 2001
    Publication date: July 3, 2003
    Inventors: Charles Morell, James Russell Fitts, Bryan D. Haynes, Leslie D. Dobbins, Donald V. Willitts, Stephen Michael Campbell, Howard Martin Welch, Todd Christopher Larson, Mark Michael Mleziva, Adrian Roy Eggen